The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan. Objective: To ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback